相关实验视频

Updated: Jun 9, 2025

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Fertility Preservation in Patients with Severe Ovarian Dysfunction

Published on: March 25, 2021

抗脂综合征对生殖结果的影响:当前见解和管理方法

Lauren He¹, Catherine Sims^1,2

¹Division of Rheumatology, University of Michigan, Ann Arbor, Michigan.

Seminars in reproductive medicine

|October 24, 2024

概括

抗脂综合征 (APS) 管理需要仔细规划,以确保成功怀孕. 本综述涵盖了APS患者的生殖健康,避孕和生育能力,突出了研究需求.

科学领域:

生殖医学是一种生殖医学.
免疫学免疫学免疫学
类风湿病学类风湿病学

背景情况:

抗脂综合征 (APS) 是通过抗脂 (aPL) 抗体,血栓形成和产科并发症来定义的.
APS可以与其他自身免疫性疾病共存,特别是系统性红斑狼,影响怀孕的结果.
虽然成功怀孕是可能的,但对于APS患者来说,具体考虑至关重要.

研究的目的:

对被诊断患有抗脂综合征 (APS) 的患者进行妊娠和生殖健康考虑的审查.
讨论管理策略,包括怀孕前的计划,药物治疗和怀孕期间的监测.
在APS中解决更广泛的生殖健康主题,如避孕,辅助生殖技术和生育能力.

主要方法:

关于抗脂综合征 (APS) 和怀孕现有研究的文献综述.
综合有关产科并发症,孕产妇和胎儿后果的信息.
讨论管理方案和治疗干预措施.

主要成果:

与风湿病学家和产科医生的预孕计划对于稳定的疾病至关重要.
怀孕管理涉及阿司匹林和/或基于个体疾病概况的抗凝药.
怀孕期间的生理变化会影响APS患者的孕产妇和胎儿后果.

结论:

在APS患者中成功怀孕需要主动管理和多学科护理.
综合性生殖健康策略,包括避孕和生育方面的考虑,是必不可少的.
需要进一步进行高质量的,基于证据的研究,以改善APS中母亲和胎儿的结果.

更多相关视频

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives

Published on: September 16, 2021

Methods for Studying Uterine Contributions to Pregnancy Establishment in an Ovariectomized Mouse Model

Methods for Studying Uterine Contributions to Pregnancy Establishment in an Ovariectomized Mouse Model

Published on: April 7, 2023

相关概念视频

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...